ABSTRACT
Infections by carbapenem-resistant Klebsiella pneumoniae (CRKp) are an increasing global threat with limited therapeutic options. Our objective was to evaluate clinical and microbiological outcomes of patients treated with amikacin for CRKp infections. We did a retrospective cohort of patients > 18 years old, with CRKp infections treated with amikacin in two tertiary care hospitals in Porto Alegre, Brazil. The impact of clinical factors, antibiotic treatment, and amikacin minimum inhibitory concentration (MIC) on patients' 30-day mortality was assessed. Microbiological clearance and nephrotoxicity (assessed by RIFLE score) were evaluated as secondary outcomes. A Cox regression analysis was done for mortality. We included 84 patients for analysis. Twenty-nine (34.5%) patients died in 30 days. Amikacin MIC values ranged from 0.125 to 8 µg/mL and did not influence on mortality, regardless of the prescribed dose of this antibiotic (P = 0.24). Bacterial clearance occurred in 17 (58.6%) of 29 patients who collected subsequent cultures. Two (16.6%) of the 12 persistently positive cultures changed the amikacin susceptibility profile from susceptible to intermediate. Twenty-nine (37.2%) patients developed acute kidney injury (AKI): risk 13, injury 11, and failure 5. Risk factors for AKI were higher baseline eGFR (P < 0.01) and combination therapy with colistin (P = 0.02). Comparing patients who received combination with colistin vs polymyxin B, AKI occurred in 60.0% vs 20.6%, respectively, P < 0.01. Fifteen of the 16 (16.6%) patients who developed renal injury or failure were receiving colistin. In conclusion, amikacin was an effective treatment for CRKp infections. Within susceptible range, amikacin MIC values did not influence on clinical outcomes. Combination therapy of amikacin and colistin was highly nephrotoxic and should be used with caution.
Subject(s)
Amikacin , Carbapenem-Resistant Enterobacteriaceae , Klebsiella Infections , Klebsiella pneumoniae , Acute Kidney Injury/drug therapy , Acute Kidney Injury/microbiology , Adult , Aged , Aged, 80 and over , Amikacin/adverse effects , Amikacin/pharmacology , Amikacin/therapeutic use , Amikacin/toxicity , Anti-Bacterial Agents/adverse effects , Carbapenem-Resistant Enterobacteriaceae/drug effects , Carbapenems/pharmacology , Colistin/adverse effects , Female , Humans , Klebsiella Infections/drug therapy , Klebsiella Infections/microbiology , Klebsiella pneumoniae/drug effects , Male , Microbial Sensitivity Tests , Middle Aged , Retrospective Studies , Treatment Outcome , Young AdultABSTRACT
We evaluated the susceptibility profile of a colonizing carbapenem-resistant enterobacteriaceae to predict its susceptibility when recovered from a clinical specimen. An overall agreement of 88.7% (517 out of 583; 95% confidence interval, 85.8%-91.0%) was observed for the combinations of 11 antibiotics with 53 pairs of Klebsiella pneumoniae carbapenemase-producing K pneumoniae (the only carbapenem-resistant enterobacteriaceae detected). Very major errors were observed mainly for aminoglycoside agents and colistin, limiting the predictability of the susceptibility profile for these clinical isolates.
Subject(s)
Anti-Bacterial Agents/pharmacology , Carbapenems/pharmacology , Carrier State/microbiology , Drug Resistance, Bacterial , Epidemiological Monitoring , Klebsiella Infections/microbiology , Klebsiella pneumoniae/drug effects , Cohort Studies , Humans , Klebsiella pneumoniae/isolation & purification , Microbial Sensitivity TestsABSTRACT
In this study, we aimed to evaluate the performance of different phenotypic tests to detect carbapenem-resistant Enterobacteriaceae. Three different phenotypic methods were evaluated: (1) combined-disk test of meropenem plus phenylboronic acid or EDTA reading after 24h and 48h; (2) selective/chromogenic read after 24h and after 48h; and (3) overnight selective enrichment broth containing 10µg ertapenem disk followed by culture on MacConkey agar. A positive result in at least one of the methods was submitted to PCR for blaNDM-1, blaOXA-48, blaKPC, blaSPM-1, blaIMP, and blaGES detection. Carbapenem-resistant Enterobacteriaceae was detected in 31 (30.4%) of 102 rectal swabs evaluated. All isolates showed to be KPC-2-producing organisms. Results showed excellent agreement among the evaluated tests (positive and negative) (kappa=0.88). It is important to state that combined-disk test with phenylboronic acid is not suitable for bacterial identification/isolation. Conversely, selective/chromogenic agar after 48h of incubation showed to be a useful tool, with the advantage of presumptive bacterial identification.
Subject(s)
Carbapenems/pharmacology , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae , beta-Lactamases/metabolism , Bacteriological Techniques/methods , Enterobacteriaceae/drug effects , Enterobacteriaceae/enzymology , Feces/microbiology , Humans , Intensive Care Units , Phenotype , Polymerase Chain Reaction , Sensitivity and Specificity , beta-Lactamases/geneticsABSTRACT
INTRODUCTION: Herpes simplex virus (HSV) and varicella zoster virus (VZV) are responsible for a variety of human diseases, including central nervous system diseases. The use of polymerase chain reaction (PCR) techniques on cerebrospinal fluid samples has allowed the detection of viral DNA with high sensitivity and specificity. METHODS: Serial dilutions of quantified commercial controls of each virus were subjected to an in-house nested-PCR technique. RESULTS: The minimum detection limits for HSV and VZV were 5 and 10 copies/µL, respectively. CONCLUSIONS: The detection limit of nested-PCR for HSV and VZV in this study was similar to the limits found in previous studies.
Subject(s)
DNA, Viral/analysis , Herpes Simplex/diagnosis , Herpes Zoster/diagnosis , Herpesvirus 3, Human/genetics , Polymerase Chain Reaction , Simplexvirus/genetics , Humans , Limit of Detection , Sensitivity and SpecificityABSTRACT
Introduction Herpes simplex virus (HSV) and varicella zoster virus (VZV) are responsible for a variety of human diseases, including central nervous system diseases. The use of polymerase chain reaction (PCR) techniques on cerebrospinal fluid samples has allowed the detection of viral DNA with high sensitivity and specificity. Methods Serial dilutions of quantified commercial controls of each virus were subjected to an in-house nested-PCR technique. Results The minimum detection limits for HSV and VZV were 5 and 10 copies/µL, respectively. Conclusions The detection limit of nested-PCR for HSV and VZV in this study was similar to the limits found in previous studies. .
Subject(s)
Humans , DNA, Viral/analysis , Herpes Simplex/diagnosis , Herpes Zoster/diagnosis , /genetics , Polymerase Chain Reaction , Simplexvirus/genetics , Limit of Detection , Sensitivity and SpecificityABSTRACT
We evaluated the use of a chromogenic selective medium (MRSA ID) as a useful tool for the detection of methicillin-resistant Staphylococcus aureus (MRSA) in cystic fibrosis (CF) patient samples. Fifty-four MRSA isolates were detected by MRSA ID, while only 24/54 (44%) (odds ratio [OR], 2.79; 95% confidence interval [CI], 1.63 to 4.76) were detected by conventional methods. A chromogenic selective medium for MRSA detection may improve its surveillance in CF patients.
